The transforming growth factor-beta pathway is a common target of drugs that prevent experimental diabetic retinopathy
about
Deletion of aldose reductase from mice inhibits diabetes-induced retinal capillary degeneration and superoxide generationProtein inhibitor of activated STAT, PIASy regulates α-smooth muscle actin expression by interacting with E12 in mesangial cellsHigh intravitreal TGF-β1 and MMP-9 levels in eyes with retinal vein occlusionIL-1β is upregulated in the diabetic retina and retinal vessels: cell-specific effect of high glucose and IL-1β autostimulation.Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative-nitrosative stress and p38 MAPK activation.Oxidative damage of mitochondrial DNA in diabetes and its protection by manganese superoxide dismutasePhotocoagulation of human retinal pigment epithelium in vitro: unravelling the effects on ARPE-19 by transcriptomics and proteomics.Beyond AREDS: is there a place for antioxidant therapy in the prevention/treatment of eye disease?Gene set enrichment analysis of pathways and transcription factors associated with diabetic retinopathy using a microarray dataset.Tetramethylpyrazine Protects Retinal Capillary Endothelial Cells (TR-iBRB2) against IL-1β-Induced Nitrative/Oxidative StressMechanism Investigation of the Improvement of Chang Run Tong on the Colonic Remodeling in Streptozotocin-Induced Diabetic Rats.Defective retinal vascular endothelial cell development as a consequence of impaired integrin αVβ8-mediated activation of transforming growth factor-β.Autophagy in Diabetic Retinopathy.Advances in our understanding of diabetic retinopathy.Development of aldose reductase inhibitors for the treatment of inflammatory disorders.From pathobiology to the targeting of pericytes for the treatment of diabetic retinopathyGlucose and acute exercise influence factors secreted by circulating angiogenic cells in vitro.Potential Therapeutic Roles for Inhibition of the PI3K/Akt/mTOR Pathway in the Pathophysiology of Diabetic Retinopathy.Emerging Roles of Transforming Growth Factor β Signaling in Diabetic Retinopathy.Is there a place for inhibition of transforming growth factor-β and the polyol pathway in therapy for diabetic retinopathy?Retinal microangiopathy in a mouse model of inducible mural cell loss.Blockade of vascular endothelial growth factor receptor 1 prevents inflammation and vascular leakage in diabetic retinopathy.The Increased Transforming Growth Factor-β Signaling Induced by Diabetes Protects Retinal Vessels.Increased intravitreal angiopoietin-2 levels associated with rhegmatogenous retinal detachment.First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery.
P2860
Q28486203-1A9C1B96-2B6D-41B3-81F7-1C9D65C16CE1Q28729019-E729DB1E-EF4B-45EF-9218-97FDE235AE50Q34200359-DC718375-D1C7-4B79-B9A9-34FBFB800C2EQ34277556-47802685-8826-46DE-A3B4-3F45A7EF25FBQ34434392-B83C3DF2-9DB6-43EB-B00E-F3CADA19FE10Q34512906-D9E3793E-EAC7-43C3-8140-E4BB7D3DC37AQ35545540-CB08D8F9-5E75-415D-8AFE-88029228B576Q35591570-5F0D9D00-12FC-48D3-B848-725D7760CF5EQ35638444-D8DA478C-E9A8-4693-9173-EB59288756C2Q36184164-76F6DF12-6066-4274-A8E4-B9A5BF07C504Q36454380-B64B0A90-A612-4DA4-AABD-25A9A8447EC4Q36626902-9C4DE40E-D2EC-44B4-A2AC-C54355D3E3FBQ37677015-D88A5955-B474-4259-B47F-B6105FB8DE07Q38088818-C14B67C7-9686-4650-9FFE-1459AA1F9C53Q38148786-788F0F25-D553-4F04-89BB-4BC57D99D2EBQ38332124-365657CA-8600-4124-87F9-E5D748DE521CQ38549001-A9B51BF6-8003-4B7D-B914-7175E1A403C2Q38895113-042B1451-A943-47A4-9B9D-2983753625ACQ38912512-E6F9B9F6-115B-4528-8824-401EFCDDA9D7Q39160411-20A8E1B5-4D2F-4428-83E1-EEACD4FBB8C6Q41816335-91737A84-1506-40BF-8AB0-1C3538ECEA44Q42123271-F1AAC425-9329-45EE-916F-23010831FC55Q42505245-E5282BC2-D3AB-41A1-B3B0-DE56DAA9DB31Q45905920-13C499FF-DE42-4B8F-9E82-16EDDB1809DCQ47105212-7C54E1F4-BA16-4123-8FE5-AC5BC24C3BBA
P2860
The transforming growth factor-beta pathway is a common target of drugs that prevent experimental diabetic retinopathy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The transforming growth factor ...... erimental diabetic retinopathy
@en
The transforming growth factor ...... rimental diabetic retinopathy.
@nl
type
label
The transforming growth factor ...... erimental diabetic retinopathy
@en
The transforming growth factor ...... rimental diabetic retinopathy.
@nl
prefLabel
The transforming growth factor ...... erimental diabetic retinopathy
@en
The transforming growth factor ...... rimental diabetic retinopathy.
@nl
P2093
P2860
P356
P1433
P1476
The transforming growth factor ...... erimental diabetic retinopathy
@en
P2093
Chiara Gerhardinger
Mara Lorenzi
Yong Seek Park
Zeina Dagher
P2860
P304
P356
10.2337/DB08-1008
P407
P577
2009-04-28T00:00:00Z